These findings indicate that expression status of ZIP10 is a major determinant for anti-tumor activity of mannose in thyroid cancer cells, and may be a potential therapeutic target to sensitize the response of cancer cells to mannose. The gene discussed is SLC39A10; the disease is thyroid gland carcinoma.